Acyclovir News
Eczema Herpeticum - Los Angeles Chronicle
Therefore, they have to be treated with the antiviral drugs like the valaciclovir or acyclovir. When this virus, herpes simples gets entry in atopic ...
Bioalliance Pharma could be attractive target but no proposal on ... - Forbes
In the first half of 2009, Bioalliance aims to file for European approval of oral herpes treatment acyclovir Lauriad, followed in the second half, it hopes, ...
Disappointing news in fight against HIV - Kansas City Star
The assumption was simple: Use acyclovir, a proven anti-herpes drug, to knock down that infection, and the odds of avoiding HIV would dramatically improve ...
Herpes drug does not prevent HIV infection: study - Canada.com
The findings raised questions about whether the drug, called acyclovir, worked well enough to stop blistering or whether herpes raises the risk of infection ...
BioAlliance Pharma Announces Its Full-Year Results for 2007 - WELT ONLINE
In fact, BioAlliance Pharma is developing Phase III clinical trial programs (Loramyc® in the United States, acyclovir Lauriad® and doxorubicin Transdrug®) ...
BioAlliance Pharma to Pursue Its Strategy for the Targeted ... - FOXBusiness
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad(R) in oral herpes (based on the same Lauriad(R) ...
BioAlliance Pharma Announces a 786% Increase in Revenues for the ... - PharmaLive.com (press release)
With regard to acyclovir Lauriad(R) in the treatment of recurrent oral herpes, the company has extended its international phase III trial to the United ...
BioAlliance Pharma to Pursue Its Strategy for the Targeted ... - FOXBusiness
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad(R) in oral herpes (based on the same Lauriad(R) ...
BioAlliance Pharma Announces a 786% Increase in Revenues for the ... - Nanowerk LLC
With regard to acyclovir Lauriad® in the treatment of recurrent oral herpes, the company has extended its international phase III trial to the United States ...
Experiment to treat genital herpes produces no protection - San Francisco Chronicle
The assumption was simple - use acyclovir, a proven anti-herpes drug, to knock down that infection, and the odds of avoiding HIV would dramatically improve ...
Acyclovir RSS Feed